Incidence of and treatment for ductal carcinoma in situ of the breast

JAMA

Volumn 275, Issue 12, 1996, Pages 913-918

  Ernster, Virginia L ^a,d   Barclay, John ^a   Kerlikowske, Karla ^a,b   Grady, Deborah ^a,b   Henderson, I Craig ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALZA CORPORATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CARCINOMA IN SITU; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PRIORITY JOURNAL; UNITED STATES;

EID: 0029995273     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.12.913     Document Type: Article

References (47)

1. Gump FE, Jicha DL, Ozello L. Ductal carcinoma in situ (DCIS): a revised concept. Surgery. 1987; 102:790-795.
2. Bassett L. Mammographic analysis of calcifications. Radiol Clin North Am. 1992;30:93-105.
3. Swanson GM, Ragheb NE, Lin C-S, et al. Breast cancer among black and white women in the 1980s. Cancer. 1993;72:788-798.
4. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1992). Bethesda, Md: National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch; July 1995.
5. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993;270:2444-2450.
6. Lynde JI. Low-cost screening mammography: results of 21,141 consecutive examinations in a community program. South Med J. 1993;86:338-343.
7. Rebner M. Noninvasive breast cancer. Radiology. 1994;190:623-631.
8. Barth A, Brenner RJ, Giuliano AE. Current management of ductal carcinoma in situ. West J Med. 1995;163:360-366.
9. Zafrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification, a study of 127 eases: correlation with estrogen and progesterone receptors, p53, and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol. 1994; 11:208-214.
10. Rosen PP, Braun DW Jr, Kinne D. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980;46:919-925.
11. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751-758.
12. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76:1197-1200.
13. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am. 1990;70:853-871.
14. Silverstein M, Cohlan BF, Gierson ED, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer. 1992;28:630-634.
15. Hetelekidis S, Schnitt SJ, Morrow M, Harris JR. Management of ductal carcinoma in situ. CA Cancer J Clin. 1995;45:244-253.
16. Solin LJ, Yeh I-T, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Cancer. 1993;71:2532-2542.
17. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast. Cancer. 1992;70:2468-2474.
18. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol. 1993;24:16-23.
19. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer. 1995;75:1310-1319.
20. Sonnenfield M, Frenna T, Weidner M, Meyer J. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy. Radiology. 1991;181:623-631.
21. Pope TL, Fechner R, Wilhelm MC, Wanebo HJ, de Paredes ES. Lobular carcinoma in situ of the breast: mammographic features. Radiology. 1988; 168:63-66.
22. Coleman EA, Kessler LG, Wun L-M, Feuer EJ. Trends in the surgical treatment of ductal carcinoma in situ of the breast. Am J Surg. 1992;164: 74-76.
23. Use of mammography - United States, 1990. MMWR Morb Mortal Wkly Rep 1990;39:621, 627-630.
24. Brown ML, Kessler LG, Rueter FG. Is the supply of mammography machines outstripping need and demand? an economic analysis. Ann Intern Med. 1990;113:547-552.
25. Ackermann SP, Brackbill RM, Bewerse BA, Cheal NE, Sanderson LM. Cancer screening behaviors among US women: breast cancer, 1987-1989, and cervical cancer, 1988-1989. MMWR CDC Surveill Summ. 1992;41:17-25.
26. Millikan R, Dressler L, Geradts J, Graham M. The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat. 1995;35:65-77.
27. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273:149-154.
28. Kramer WM, Rush BF Jr. Mammary duct proliferation in the elderly. Cancer. 1973;31:130-137.
29. Nielsen M, Jensen J, Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy: a study of 83 women. Cancer 1984;54:612-615.
30. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol. 1985;16:796-807.
31. Bhathal PS, Brown RW, Lesueur GC, Russell IS. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer. 1985;51:271-278.
32. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56:814-819.
33. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. Cancer. 1987;60:2751-2760.
34. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B, Collaborating NSABP Investigators. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol. 1991;47:139-147.
35. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM, Collaborating NSABP Investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6), I: intraductal carcinoma (DCIS). Cancer. 1986;57:197-208.
36. van Dongen JA, Holland R, Peterse JL, et al. Ductal carcinoma in-situ of the breast: second EORTC consensus meeting. Eur J Cancer. 1992; 28:626-629.
37. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-1586.
38. Carpenter R, Boulter PS, Cooke T, Gibbs NM. Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg. 1989;76: 564-567.
39. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. Am J Surg Pathol. 1992; 16:1183-1196.
40. Faggiano F, Zanetti R, Costa G. Cancer risk and social inequalities in Italy. J Epidemiol Community Health. 1994;48:447-452.
41. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102-1107.
42. Osteen RT, Karnell LH. The National Cancer Data Base report on breast cancer. Cancer. 1994; 73:1994-2000.
43. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda, Md: National Cancer Institute; 1994. National Institutes of Health publication 94-2789.
44. Berg JW, Hutter RVP. Breast cancer. Cancer 1995;75:257-269.
45. Page DL, Rogers LW. Carcinoma in situ (CIS). In: Page DL, Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingston; 1987:157-192.
46. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994;11:167-180.
47. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154-1157.